Asia Pacific Wound Care Biologics Market, By Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth Factors), By Application (Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds(Surgical W

Asia Pacific Wound Care Biologics Market, By Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth Factors), By Application (Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds(Surgical Wounds, Burns)), By End User (Hospital (In-patient Settings and Out-patient Settings), Clinics, Ambulatory Surgical Centers, and Home Care Settings), and By Country (China, India, Japan, Australia, South Korea, ASEAN, and Rest of APAC) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Wound care biologics are bioengineered products used for non-healing wounds of the lower extremity. Wound care biologic dressings are increasingly used in post surgeries and severe trauma cases, as they provide a moist healing environment aiding heat, protein, and electrolyte loss for faster healing and prevent bacterial contamination. Biologic skin substitutes are healing therapies intended to facilitate innate repair mechanisms, control associated pain, and promote healing of the wound. Enzyme-based formulations including collagen play an essential role in wound healing such as hemostasis, inflammation, and remodeling, as collagen facilitates wound healing through the organization and accumulation of freshly formed fibers and granulation tissue, creating a healing environment. Growth factors are polypeptides that control the growth, differentiation, and metabolism of cells. These factors are hormone-like molecules that interact with specific cell surface receptors to control the process of tissue repair.

Market Dynamics

Rising medical tourism in Asia Pacific is encouraging an influx of foreign patients for affordable treatment. This had been facilitating hospitals, wound care clinics, and ambulatory surgical care centers to expand the range of wound care biologics products that are used post-surgical interventions for wound management. For instance, according to data published by Health Analytics Asia, a data-driven platform to bring journalists, doctors, and data scientists together to shape health reporting in Asia, in 2019, it had been reported that one million medical tourists visited Malaysia and 3.3 million medical tourists visited Thailand in 2017. India also saw a surge from 4,27,014 medical tourists in 2016 to 4,95,056 medical tourists in 2017.

Key features of the study:

• This report provides an in-depth analysis of the Asia Pacific wound care biologics market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Asia Pacific Wound Care Biologics Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Smith & Nephew Plc, Organogenesis, Inc., Integra LifeSciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amnio Technology LLC, Osiris Therapeutics, Inc., Anika Therapeutics, Inc., Zimmer Biomet, Wright Medical Group N.V., and Kerecis
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Asia Pacific Wound Care Biologics Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Asia Pacific wound care biologics market

Detailed Segmentation:

• Asia Pacific Wound Care Biologics Market, By Product Type:
• Biologic Skin Substitutes
• Enzyme Based Formulations
• Growth Factors
• Asia Pacific Wound Care Biologics Market, By Application:
• Chronic Wounds
• Diabetic Foot Ulcers
• Venous Leg Ulcers
• Pressure Ulcers
• Acute Wounds
• Surgical Wounds
• Burns
• Asia Pacific Wound Care Biologics Market, By End User:
• Hospitals
• In-patient Settings
• Out-patient Settings
• Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Asia Pacific Wound Care Biologics Market, By Country:
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
• Company Profiles
• Smith & Nephew Plc *
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Organogenesis, Inc.
• Integra LifeSciences Holdings Corporation
• Skye Biologics
• Alphatec Holdings, Inc.
• Solsys Medical LLC
• Amnio Technology LLC
• Osiris Therapeutics, Inc.
• Anika Therapeutics, Inc.
• Zimmer Biomet
• Wright Medical Group N.V.
• Kerecis

“*” marked represents similar segmentation in other categories in the respective section.